Rapamune®

Wyeth (USA)

• Immunosuppressant “indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiving renal transplants”

Data Source: http://www.wyeth.com

• Uses Elan’s NanoCrystal Technology to provide “more convenient administration and storage than Rapamune oral solution.”
• Approved by the FDA in August 2000

Data Source: http://www.elan.com/edt/nanocrystal_technology/default.asp